Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

Bi-lateral HGN Therapy in Real-World Patients -Post Approval Research Investigation

← catalyst calendar

NCT07331285 · readout ≤ 804 d

Sponsored by Nyxoah Inc. (industry) · NYXH.BR — their whole pipeline →.

Phase
Status
Recruiting
Study type
Observational
Enrollment
229estimated
Sites
2
Country
United States

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
StartJun 2026estimatedWhen the study began enrolling
Primary completionOct 2028estimatedThe date the last participant is measured for the primary outcome — the readout window
Study completionOct 2032estimatedThe whole study's end, after follow-up
First posted2026-01-09actualWhen this record first appeared on the registry
Results postedWhen the sponsor posted results to the registry
Record updated2026-06-22actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Condition

  • Obstructive Sleep Apnea

Intervention

  • Device: This is a single arm study, all consented and eligible subjects will be implanted with the Genio® System 2.1 — also filed as Genio Therapy

Primary outcomes

what the primary-completion date above is the date OF
Change in Apnea Hypopnea Index (AHI4%)
measured 12 months
Change in Oxyhemoglobin Desaturation Index (ODI4%)
measured 12 months
Device related SAEs
measured 12 months
Device-related and procedure-related SAEs
measured 12 months

Publications

Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.

Permalink · NYXH.BR's whole pipeline · Catalyst calendar · Every registered study · What changed